Mike Withrow, Abattis Bioceuticals Corp. CEO, is Interviewed on
CEONews.Tv
VANCOUVER, British Columbia,
Jan. 24, 2013 /PRNewswire/
-- CEO Mike Withrow of Abattis Bioceuticals Corp.
www.abattis.com (OTCPINK: ATTBF) (CNSX: FLU), a specialty
biotechnology company engaged in the licensing, marketing and
formulation of unique and proprietary botanical, vitamin, and
mineral products in several high growth natural health categories,
has been interviewed on CEONews.Tv, a financial news network. The
interview is available at: http://www.ceonews.tv/attbf/
In the interview Withrow said, "We are currently examining
various botanical plants... for compounds and ingredients to go
into our natural health products, that are proprietary to our
company, to give us that competitive edge in the market."
He also pointed out that recent changes in the laws of the
states of Washington and
Colorado, concerning the
decriminalization and legalization of marijuana, have presented new
opportunities for Abattis. He said that "we see that as quite a
large opportunity to get into a fragmented business." He went on to
state that "we have the ability to be a pharmaceutical grade
production facility with the equipment we have and the way that it
is designed."
In conclusion, Mr. Withrow shared his confidence in and his
vision for the future of Abattis Bioceuticals - "We have
intellectual property. We have a great pipeline of products. We
have great people that have proven themselves in Fortune 100
companies... and we think that there's great value."
About Abattis Bioceuticals Corp.:
Abattis Bioceuticals
Corp. is a specialty biotechnology company with capabilities,
through its wholly owned subsidiaries, of producing, licensing and
marketing proprietary ingredients and bio-similar compounds for use
in Pharmaceuticals, Nutraceutical, Cosmetic and Animal Nutrition
markets. The company also has a deep pipeline of proprietary
products ready for sale in the high growth sectors of the
Functional Foods and Supplements business. For more information,
visit the Company's website at www.abattis.com.
About CEONews:
CEONews.Tv (a division of West-Main
Communications, LLC) is an online, market news provider that brings
investors – "Big News For The SmallCap Market!"TM. CEONews.Tv
offers a number of innovative platforms that allow CEOs, CFOs,
COOs, Presidents and Directors of companies to deliver answers to
the questions that investors would like asked. Through these
mediums Executives share their insights, accomplishments, current
projects, daily challenges they face and future goals and
aspirations they have for the companies that they lead. For further
information please visit http://www.ceonews.tv, send an email to:
interviews@ceonews.tv or call 765-CEONEWS (236-6397).
Contacts:
Abattis Bioceuticals Corp.
Mike Withrow President & CEO
778.908.6650
www.abattis.com
CEONews.Tv
Charles Sample II
765-CEO-NEWS (236-6397)
charles@ceonews.tv
interviews@ceonews.tv
www.ceonews.tv
SOURCE CEONews.Tv
